Objectives:
The specific aim of this study was to evaluate whether the lower oxygenated blood to the brain, as in fetuses with transposition of great arteries (TGA), is associated with biometry, and cerebral blood flow in a large multicentre cohort. Methods: The biometry and hemodynamics parameters were retrospectively analysed in 62 fetuses with TGA from multicentre study. All the fetuses were divided into two groups: the second trimester group and the third trimester group. The second trimester group was further divided into two subgroups (with vs. without ventricular septal defect). A control group with gestational age-matched fetuses served as comparison. The PI in MCA and umbilical artery (UA), the cerebroplacental ratio (CPR) and biparietal diameter (BPD) were compared between different groups.
Results: Of all 62 fetuses, 51 fetuses were in the second-trimester of pregnancy and 11 fetuses were in the third-trimester of pregnancy. There was no significant difference in the BPD, MCA-PI, UA-PI and CPR between the second trimester and third trimester groups and among the subgroups (p > 0.05).
Conclusions:
The altered oxygen saturation to the cerebral circulation as in TGA does not affect the brain biometry and hemodynamics in fetus in the mid-and late-gestational age period. Other reasons may contribute to the neurodevelopmental outcome in TGA.
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The added value of 3D/4DUS high definition power Doppler, TUI and B-flow to the evaluation of the fetal precordial venous system Objectives: We showed that the addition of 3D/4DUS to 2DUS imaging, increased detection rates and diagnostic precision of fetal cardiovascular anomalies by 6%. We sought to determine if the addition of 3D/4DUS with the new HDPD modality, tomographic ultrasound imaging (TUI) and B-flow contributed to the detection and precision of diagnosis of defects to the fetal precordial venous system. Methods: We reviewed all cases of precordial venous anomalies diagnosed in our ultrasound centre from 2008-2017. Cases were categorised based on the affected embryonic source veins as follows: umbilical-portal vein system (n=40), vitelline vein (n=5), and cardinal vein anomalies (n=23). By comparing stored 2DUS gray-scale and Doppler cineloop files with stored 3D/4DUS and 3D4D HDPD volumes with TUI and B-flow, we estimated the added value of these modalities to the detection, or diagnostic precision, of each case and each category. Results: During the study period 68 precordial venous system defects were diagnosed in our ultrasound centre. The umbilical-portal system anomalies, intrahepatic portal system shunt: 9/19; extrahepatic portal system shunt: 8/21 had improved diagnosis by application of these modalities. In the vitelline vein system: diagnosis of 2/5 was improved with these modalities; in the cardinal vein system, diagnosis of 0/16 cases of PLSVC and 4/7 cases of interrupted IVC were improved with these modalities. Conclusions: 3D/4DUS modalities such as B-flow and TUI enhanced with HDPD are an indispensable part of the comprehensive evaluation of precordial venous anomalies. In 33.8% of cases these modalities contributed to the detection or improved diagnostic precision of venous anomalies.
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Objectives: Congenital heart defect (CHD) is the one of the major causes for neonatal lethality. And ultrasound screening enables the early diagnosis of CHD in prenatal stage. Emerging studies by using chromosomal microarray analysis of prenatal samples show that pathogenic copy number variants (CNVs) are highly associated with CHD. Methods: Here, we collected DNA samples from 145 unrelated fetuses with CHD diagnosed by ultrasound screening and subjected them for CNV analysis by low-pass whole-genome sequencing. CNV classification was performed according to the guideline from the American College of Medical Genetics. Maternal ages are 27.6±3.73, while the gestational weeks are 24.4±5.2. Sixty-one samples out of them are intra-cardiac defects (42.1%) and the remaining samples are extra-cardiac abnormalities (57.9%).Subtype classification of two groups is different, in intracardiac defect, the top were TOF (21.3%), TGA(14.8%) and AVSD (11.8%), while, the other were VSD (21.4%), AVSD (16.7%) and PS (13.1%). Results: Aneuploidies were identified in 29 (20%) fetuses, 27 out of them were with extra-cardiac abnormalities. Pathogenic CNVs were detected in seven cases, including a heterozygous loss at 22q13 harbouring FBLN1 and a gain at 10q23.31q26.3 with SHOC2 and ANKRD1.There were 344 unknown clinical significance micro-duplication or micro-deletion found in 91 samples, the number of CNV per sample was more in extra-cardiac abnormalities group when compared to intra-cardiac defect (p-value = 0.1514). 7.53% of which were predicted to be pathogenic by DECIPHER and GeneReviews. Conclusions: Our study demonstrates the potential clinical diagnostic utility of genomic imbalance profiling in CHD patients. Objectives: It is expected that many pregnant women will choose for NIPT instead of first trimester combined testing (ftCT). As a consequence high risk pregnancies may be identified later on in the pregnancy. NIPT performed in high risk pregnancies may lead to a diagnostic delay of some chromosome aberrations. The aim of this study was to evaluate the risk of a diagnostic delay in our cohort of high risk pregnancies tested with NIPT. Methods: 2014-2015 NIPT was performed in 1071 high risk pregnancies (risk > 1:200 after ftCT). 39 (3.6%) women subsequently chose array testing due to further doubts (10), an ultrasound anomaly found later on in the pregnancy (21) or fetal death (IUFD, 8) . Results: In 3 fetuses a pathogenic fetal unbalanced chromosome aberration matching the indication was found (isochromosome Xq, a de novo atypical 22q11 microdeletion and triploidy). Thus, in ca. 1:350 (3/1071) ''false'' reassurance was given with normal NIPT results and a diagnostic delay to the second trimester occurred. This is an underestimation of the overall diagnostic delay since not all unbalanced chromosome aberrations manifest ultrasound anomalies or cause IUFD. Besides this, developmental delay and intellectual disability are not immediately evident at birth. Conclusions: As the detection of severe chromosome disorders is more traumatic when discovered late in pregnancy and both the medical as well as psychological impact of a pregnancy termination are more severe, it is important to avoid diagnostic delay. Thus, it is of importance to identify high risk pregnancies either through searching for (new) early ultrasound markers or to offer higher resolution NIPT for all clinically significant unbalanced chromosome aberrations.
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Fetal homozygous α 0 -thalassemia prediction using three-dimensional sonographic placental volume in first trimester F. Yang, S. Liao
Obstetrics and Gynecology, Nan Fang Hospital, Guangzhou, China
Objectives: This perspective study aims to investigate the values of placenta volume and the placental volume/Crown-rump length quotient (PQ) on predicting fetal homozygousα 0 -thalassemia (Hb-Bart's disease) by three-dimensional (3D) sonography in first trimester. Methods: From September 2015 to December 2016, two dimensional (2D) ultrasound and 3D ultrasound sonography were performed on singleton pregnancies at risk of α0-thalassemia and normal controls at 7-13+6 weeks of gestation. Affected pregnancies were further confirmed by DNA analysis. Placental volume was measured on 3D ultrasound by a virtual organ computer-aided analysis (VOACL) technique. The interclass correlation coefficient (ICC) was used to analyse the inter-and intraobserver reliability of the 3D ultrasound measurements of 40 fetuses. PQ of the affected pregnancies was compared with that of normal fetuses. Results: Of the 577 fetuses studied, 258 were at risk of a 0 -Thalassemia and 319 were normal controls. 56 (9.71%) fetuses were affected by α 0 -thalassemia. α 0 -thalassemia fetuses all came from the at-risk group while the others were normal. The inter-and intraobserver variability for placental volume by 3D ultrasound measurement was small (inter-and intraclass correlation coefficient were 0.947 and 0.994 respectively). PQ of homozygous α 0 -thalassemia pregnancies showed significant increase compared with that in unaffected group (1.25 ±0.08 vs. 0.94 ± 0.01, P<0.001). PQ ≥ 1.22 was a practical predictor to fetuses with homozygous α 0 -thalassemia with a sensitivity of 53.6%, specificity of 82.7% and an AUC of 0.67 (p < 0.001). Conclusions: Placental volume by 3D ultrasound could be an applicable factor in the first-trimester prediction of fetal homozygous α 0 -thalassemia. Thus may have clinical significance and become a non-invasive technique for early prediction of α 0 -thalassemia.
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Objectives: Use of invasive prenatal diagnosis (IPD) in hepatitis B surface antigen (HBsAg)-positive women carries a potential risk of vertical transmission especially when the viral load is high. The objective of the present study is to investigate HBsAg-positive women's uptake of invasive prenatal diagnosis (IPD) after a positive conventional aneuploidy screening. We hypothesis that more HBSAg-positive than-negative women would choose cell free DNA (cfDNA) testing to avoid IPD and its potential risk of vertical transmission.
